Profiling of Ecstasy Tablets Seized in Iran

被引：0

作者：

Khajeamiri, Ali Reza ^{[2
]}

Kobarfard, Farzad ^{[1
,6
]}

Ahmadkhaniha, Reza ^{[3
,4
]}

Mostashari, Gelareh ^{[5
]}

机构：

[1] Shahid Beheshti Univ MS, Sch Pharm, Dept Med Chem, Tehran, Iran

[2] Shahid Beheshti Univ MS, Sch Pharm, Dept Toxicol, Tehran, Iran

[3] Tehran Univ MS, Sch Pharm, Dept Med Chem, Tehran, Iran

[4] Doping Control Lab, Tehran, Iran

[5] UNODC, Tehran, Iran

[6] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran

来源：

IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2011年 / 10卷 / 02期

关键词：

Ecstasy; TLC; Amphetamine-Type Stimulants (ATS); 3,4-methylenedioxymethamphetamine - (MDMA); MDMA;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In this study 50 samples of ecstasy tablets seized in Iran during the period of 2007 through 2008 were examined and their physical characteristics (appearance, marking, scored/not scored, color, weight, diameter, thickness) were determined. In order to determine the chemical characteristics of these tablets, color tests (Marquis test, Simon's test, Chen's test and Gallic acid test), Thin Layer Chromatography (TLC), anion test, residual solvents, Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were carried out on the tablets. The range of tablets weight was 96-308 mg and the range of 3,4-methylenedioxymethamphetamine (MDMA) hydrochloride content in these tablets was 60180 mg. No good correlation was found between the tablets weight and their MDMA contents. All of the tablets containing MDMA had this compound in hydrochloride form. Ketamine, phenmetrazine and ephedrine (or pseudoephedrine) were found in some of the tablets along with MDMA. No MDMA was found in 10% of the tablets. Some of these tablets contained compounds such as caffeine or tramadol as their active ingredient.

引用

页码：211 / 220

页数：10

共 50 条

[21] Ecstasy tablets: Rapid identification and determination of enantiomeric excess of MDMA
Fagan, Patrik
Spalovska, Dita
Kuchar, Martin
Cernohorsky, Tomas
Komorousova, Ludmila
Kocourkova, Lucie
Setnicka, Vladimir
FORENSIC CHEMISTRY, 2021, 26
[22] Graphite furnace atomic absorption elemental analysis of ecstasy tablets
French, Holly E.
Went, Michael J.
Gibson, Stuart J.
FORENSIC SCIENCE INTERNATIONAL, 2013, 231 (1-3) : 88 - 91
[23] Separation of positional CPP isomers by chiral HPLC-DAD of seized tablets
Schuerenkamp, Jennifer
Beike, Justus
Pfeiffer, Heidi
Koehler, Helga
INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2011, 125 (01) : 95 - 99
[24] Headspace solid-phase microextraction - gas chromatography - mass spectrometry qualitative screening method for active compounds, adulterants and impurities in ecstasy tablets seized in Northern Santa Catarina State, Brazil
Nicolodi, Caroline
Slominski, William Henrique
Parabocz, Gisele Chibinski
Pericolo, Suellen
Da-Col, Jose Augusto
Martendal, Edmar
FORENSIC SCIENCE INTERNATIONAL, 2024, 355
[25] Analysis of ecstasy tablets: comparison of reflectance and transmittance near infrared spectroscopy
Schneider, RC
Kovar, KA
FORENSIC SCIENCE INTERNATIONAL, 2003, 134 (2-3) : 187 - 195
[26] Life expectancy of "ecstasy" tablets in Israel in the years 2001-2003
Levy, Rina
Zelkowicz, Avraham
Abu, Ester
Ravreby, Mark D.
FORENSIC SCIENCE INTERNATIONAL, 2007, 167 (01) : 22 - 29
[27] Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users
Brunt, Tibor M.
Koeter, Maarten W.
Niesink, Raymond J. M.
van den Brink, Wim
PSYCHOPHARMACOLOGY, 2012, 220 (04) : 751 - 762
[28] The content of ecstasy tablets: implications for the study of their long-term effects
Cole, JC
Bailey, M
Sumnall, HR
Wagstaff, GF
King, LA
ADDICTION, 2002, 97 (12) : 1531 - 1536
[29] Sugar and fatty acid analysis in ecstasy tablets
Baer, Ines
Margot, Pierre
FORENSIC SCIENCE INTERNATIONAL, 2007, 167 (2-3) : 229 - 233
[30] Pharmacological content of tablets sold as "ecstasy": Results from an online testing service
Tanner-Smith, Emily E.
DRUG AND ALCOHOL DEPENDENCE, 2006, 83 (03) : 247 - 254

← 1 2 3 4 5 →